(lp0
S'MediciNova Inc. MNOV  Wall Street Journal - Feb 11, 2011 News MediciNova Inc.MNOV. Significant News Only. 02/27/17; Press Release. MediciNova Announces MN-166  Glioblastoma Abstract Selected for Presentation at the 5th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies&nbsp;...'
p1
aS'MediciNova Inc.  Moves Lower on Volume Spike for March 22 Equities.com - Mar 22, 2017 MediciNova Inc.  traded on unusually high volume on Mar. 22, as the stock lost 0.17% to close at $5.80. On the day, MediciNova Inc. saw 57,460 shares trade hands on 399 trades. Considering that the stock averages only a daily volume of 33,493&nbsp;...'
p2
aS'MediciNova Inc.  Soars 5.74% on February 27 Equities.com - Feb 27, 2017 MediciNova Inc.  had a good day on the market for Monday February 27 as shares jumped 5.74% to close at $6.45. About 58,763 shares traded hands on 511 trades for the day, compared with an average daily volume of 72,676 shares out of a total&nbsp;...'
p3
aS'MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN ... GlobeNewswire  - Jul 24, 2016 LA JOLLA, Calif., July 24, 2016  -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market  and the JASDAQ Market of the Tokyo Stock Exchange , today announced&nbsp;...'
p4
aS'MediciNova Gets Fast Tracked Into Thick Of NASH Race Seeking Alpha - Apr 16, 2015 Today, MediciNova  announced that it has received Fast Track designation from the U.S. Food and Drug Administration  for tipelukast  for the treatment of NASH with fibrosis.Tokyo Stock Exchange Announces New Rule Affecting Trading of MediciNova Stock ... - GlobeNewswire '
p5
aS"MediciNova's Ibudilast And The Phase IIb Trial Offer Steady Outlook Seeking Alpha - Jan 18, 2016 Recent news surrounding Medicinova's  progress has concerned its drug MN-166, or ibudilast, and its treatment of ALS, commonly known as Lou Gehrig's disease."
p6
aS"Stock Spotlight: Looking at the Levels for MediciNova, Inc.  Davidson Register - 14 hours ago MediciNova, Inc. 's 12 month volatility is presently 54.590900. The 6 month volatility is seen at 34.995300, and the 3 month is seen at 31.199000."
p7
aS'MediciNova Announces MN-166  Glioblastoma Abstract Selected for ... GlobeNewswire  - Feb 27, 2017 LA JOLLA, Calif., Feb. 27, 2017  -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market  and the JASDAQ Market of the Tokyo Stock Exchange , today announced&nbsp;...'
p8
aS'MediciNova Inc Stock Volatility Hits A Tumbling Low CML News - Mar 5, 2017 This is a proprietary realized volatility rating created by Capital Market Laboratories  based on a large number of data interactions for MediciNova Inc  . We examine the little used gem of daily stock volatility over a 20-day and ...'
p9
aS'MediciNova Announces Initiation of Interim Efficacy Analysis in Phase 2b Trial ... GlobeNewswire  - Jul 13, 2016 LA JOLLA, Calif., July 13, 2016  -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market  and the JASDAQ Market of the Tokyo Stock Exchange , today announced&nbsp;...'
p10
a.